Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2019 1
2020 1
2021 2
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
HAPLN1 potentiates peritoneal metastasis in pancreatic cancer.
Wiedmann L, De Angelis Rigotti F, Vaquero-Siguero N, Donato E, Espinet E, Moll I, Alsina-Sanchis E, Bohnenberger H, Fernandez-Florido E, Mülfarth R, Vacca M, Gerwing J, Conradi LC, Ströbel P, Trumpp A, Mogler C, Fischer A, Rodriguez-Vita J. Wiedmann L, et al. Among authors: mulfarth r. Nat Commun. 2023 Apr 24;14(1):2353. doi: 10.1038/s41467-023-38064-w. Nat Commun. 2023. PMID: 37095087 Free PMC article.
Endothelial Notch1 signaling in white adipose tissue promotes cancer cachexia.
Taylor J, Uhl L, Moll I, Hasan SS, Wiedmann L, Morgenstern J, Giaimo BD, Friedrich T, Alsina-Sanchis E, De Angelis Rigotti F, Mülfarth R, Kaltenbach S, Schenk D, Nickel F, Fleming T, Sprinzak D, Mogler C, Korff T, Billeter AT, Müller-Stich BP, Berriel Diaz M, Borggrefe T, Herzig S, Rohm M, Rodriguez-Vita J, Fischer A. Taylor J, et al. Among authors: mulfarth r. Nat Cancer. 2023 Nov;4(11):1544-1560. doi: 10.1038/s43018-023-00622-y. Epub 2023 Sep 25. Nat Cancer. 2023. PMID: 37749321 Free PMC article.
Control of Tumor Progression by Angiocrine Factors.
Alsina-Sanchis E, Mülfarth R, Fischer A. Alsina-Sanchis E, et al. Among authors: mulfarth r. Cancers (Basel). 2021 May 26;13(11):2610. doi: 10.3390/cancers13112610. Cancers (Basel). 2021. PMID: 34073394 Free PMC article. Review.
Endothelial RBPJ Is Essential for the Education of Tumor-Associated Macrophages.
Alsina-Sanchis E, Mülfarth R, Moll I, Böhn S, Wiedmann L, Jordana-Urriza L, Ziegelbauer T, Zimmer E, Taylor J, De Angelis Rigotti F, Stögbauer A, Giaimo BD, Cerwenka A, Borggrefe T, Fischer A, Rodriguez-Vita J. Alsina-Sanchis E, et al. Among authors: mulfarth r. Cancer Res. 2022 Dec 2;82(23):4414-4428. doi: 10.1158/0008-5472.CAN-22-0076. Cancer Res. 2022. PMID: 36200806
An effective cell-penetrating antibody delivery platform.
Herrmann A, Nagao T, Zhang C, Lahtz C, Li YJ, Yue C, Mülfarth R, Yu H. Herrmann A, et al. Among authors: mulfarth r. JCI Insight. 2019 Jul 25;4(14):e127474. doi: 10.1172/jci.insight.127474. eCollection 2019 Jul 25. JCI Insight. 2019. PMID: 31341104 Free PMC article.
CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity.
Herrmann A, Lahtz C, Nagao T, Song JY, Chan WC, Lee H, Yue C, Look T, Mülfarth R, Li W, Jenkins K, Williams J, Budde LE, Forman S, Kwak L, Blankenstein T, Yu H. Herrmann A, et al. Among authors: mulfarth r. Cancer Res. 2017 Sep 15;77(18):5118-5128. doi: 10.1158/0008-5472.CAN-16-0342. Epub 2017 Jul 17. Cancer Res. 2017. PMID: 28716895 Free PMC article.
Capitalizing on paradoxical activation of the mitogen-activated protein kinase pathway for treatment of Imatinib-resistant mast cell leukemia.
Wilhelm T, Toledo MAS, Simons I, Stuth C, Mohta V, Mülfarth R, Nitsche M, Maschke-Neuß K, Schmitz S, Kaiser A, Panse J, Christen D, Arock M, Zenke M, Huber M. Wilhelm T, et al. Among authors: mulfarth r. Hematol Oncol. 2023 Aug;41(3):520-534. doi: 10.1002/hon.3100. Epub 2022 Nov 30. Hematol Oncol. 2023. PMID: 36383121